Literature DB >> 21956147

Combination surgery for erectile dysfunction and male incontinence.

Dominic Lee1, O Lenaine Westney, Run Wang.   

Abstract

With favorable prognosis, radical therapy for pelvic malignancy no longer is just about oncological control, but is important in achieving the trifecta of oncological clearance with acceptable sexual function and urinary outcomes. As we face the prospect of escalating urogenital dysfunction following our radical interventions, we need to carefully assess these functional outcomes and their impact on the quality of life of our patients. In men, this includes urinary impairments with stress urinary incontinence, various types of voiding dysfunction, and sexual impairments (primarily erectile dysfunction and orgasmic dysfunction). Based on appropriate clinical and diagnostic assessments of severity of adverse outcomes depending on patient preference, combination surgery for treatment of erectile dysfunction and stress urinary incontinence is effective and durable and has an established, definitive role to address this not uncommon problem. This article reviews the prevalence of the problem, the available therapeutic options, and evidence of efficacy of these therapies in combination.

Entities:  

Mesh:

Year:  2011        PMID: 21956147     DOI: 10.1007/s11934-011-0220-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  51 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Cost and time benefits of dual implantation of inflatable penile and artificial urinary sphincter prosthetics by single incision.

Authors:  Clay L Sellers; Allen F Morey; LeRoy A Jones
Journal:  Urology       Date:  2005-05       Impact factor: 2.649

3.  Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.

Authors:  F Montorsi; G Guazzoni; L F Strambi; L F Da Pozzo; L Nava; L Barbieri; P Rigatti; G Pizzini; A Miani
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

4.  The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence.

Authors:  M Abdurrahim Imamoglu; Can Tuygun; Hasan Bakirtas; Orhan Yiğitbasi; Ahmet Kiper
Journal:  Eur Urol       Date:  2005-02       Impact factor: 20.096

5.  Comparison of bone-anchored male sling and collagen implant for the treatment of male incontinence.

Authors:  Rahmi Onur; Ajay Singla
Journal:  Int J Urol       Date:  2006-09       Impact factor: 3.369

Review 6.  Urinary and sexual dysfunction after rectal cancer treatment.

Authors:  Marilyne M Lange; Cornelis J H van de Velde
Journal:  Nat Rev Urol       Date:  2010-12-07       Impact factor: 14.432

7.  Artificial urinary sphincter for post-radical prostatectomy urinary incontinence: long-term subjective results.

Authors:  A E Gousse; S Madjar; M M Lambert; I J Fishman
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

8.  Transrectal ultrasound-guided implantation of Adjustable Continence Therapy (ProACT): surgical technique and clinical results after a mean follow-up of 2 years.

Authors:  Andrea Gregori; Ai Ling Romanò; Francesco Scieri; Francesco Pietrantuono; Giacomo Piero Incarbone; Antonio Salvaggio; Antonio Granata; Franco Gaboardi
Journal:  Eur Urol       Date:  2009-11-21       Impact factor: 20.096

9.  Fibrosis of corpus cavernosum in animals following cavernous nerve ablation.

Authors:  Wan-Li Hu; Li-Quan Hu; Jian Song; Shi-Wen Li; Xin-Min Zheng; Bei Cheng; Bing-Chun Tian
Journal:  Asian J Androl       Date:  2004-06       Impact factor: 3.285

10.  Combination therapy for male erectile dysfunction and urinary incontinence.

Authors:  Helen Zafirakis; Run Wang; O Lenaine Westney
Journal:  Asian J Androl       Date:  2008-01       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.